Johnson & Johnson: all 3,718 studies

Page 16 of 38. Open to participants first (155), then studies with results posted, then the rest; newest registration first within each.

• Evaluating Quality of Life Benefits of ACUVUE® Theravision® With Ketotifen in Subjects With Ocular AllergiesWithdrawnNCT05530889Not applicable
• IMpella-Protected cArdiaC Surgery Trial (IMPACT)CompletedNCT05529654Not applicable
• A Twelve Week Study of Prototypes Mouth RinsesCompletedNCT05526586Phase 4
• A Study Validating the Use of Candin as a Challenge Agent in Healthy Participants - Intervention Specific Appendix 4CompletedNCT05522517Phase 1
• A Study of JNJ-75276617 in Combination With Conventional Chemotherapy for Pediatric and Young Adult Participants With Relapsed/Refractory Acute LeukemiasWithdrawnNCT05521087Phase 1
• A Study of ECHELON 3000 (Next Generation Powered Stapler) in General Abdominal and Thoracic Lung Resection ProceduresCompletedNCT05519215
• The RECOVER IV TrialTerminatedNCT05506449Not applicable
• Pre-Approval Access Single Patient Request for Talquetamab in Relapsed or Refractory Multiple MyelomaNo longer availableNCT05503550
• A Study of Amivantamab and Capmatinib Combination Therapy in Unresectable Metastatic Non-small Cell Lung CancerActive, not recruitingNCT05488314Phase 1/2
• Breethe Abiomed Recovery RegisTry (BART)CompletedNCT05473130
• A PET Study Following a Single Oral Dose of ITI-333 in Healthy SubjectsCompletedNCT05470101Phase 1
• Teclistamab Expanded Access Treatment Protocol for Relapsed or Refractory Multiple Myeloma PatientsApproved for marketingNCT05463939
• Clinical Investigation of Refraction TechniquesCompletedNCT05461586
• A Study of Comparing Talquetamab to Belantamab Mafodotin in Participants With Relapsed/Refractory Multiple MyelomaWithdrawnNCT05461209Phase 3
• A Study Comparing Talquetamab in Combination With Daratumumab or in Combination With Daratumumab and Pomalidomide Versus Daratumumab in Combination With Pomalidomide and Dexamethasone in Participants With Multiple Myeloma That Returns After Treatment or is Resistant to TreatmentActive, not recruitingNCT05455320Phase 3
• A Study of Bleximenib in Combination With Acute Myeloid Leukemia (AML) Directed TherapiesActive, not recruitingNCT05453903Phase 1
• A Study of VAC85135, a Neoantigen Vaccine Regimen, Concurrently Administered With Ipilimumab for the Treatment of Myeloproliferative NeoplasmsCompletedNCT05444530Phase 1
• A Study of JNJ-80038114 in Participants With Advanced Stage Prostate CancerCompletedNCT05441501Phase 1
• A Study of DaratumumabActive, not recruitingNCT05438043Phase 3
• A Study of Two Macitentan Formulations in Healthy Adult ParticipantsCompletedNCT05433675Phase 1
• A Study of Single and Multiple Doses of Different Formulations of a Prostacyclin Receptor AgonistCompletedNCT05427162Phase 1
• A Study of Robot-Assisted Bronchoscopy in Chinese Participants With Lung LesionsWithdrawnNCT05426213Not applicable
• A Study of JNJ-80948543, a T-cell Redirecting CD79b x CD20 x CD3 Trispecific Antibody, in Participants With Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)Active, not recruitingNCT05424822Phase 1
• A Single and Multiple Ascending Dose Study of JNJ-64457744TerminatedNCT05423106Phase 1
• A Study of JNJ-90014496 in Participants With B-Cell Non-Hodgkin LymphomaActive, not recruitingNCT05421663Phase 1/2
• A Study of Participants Undergoing Radial Head Replacement Using the DePuy Synthes Radial Head Replacement System for Partial Replacement of the Elbow JointWithdrawnNCT05415592
• A Study of JNJ-63733657 in Healthy Chinese ParticipantsCompletedNCT05407818Phase 1
• Pre-approval Access Single Patient Request for Niraparib / Abiraterone Acetate Combination (Nira/AA Combination)Approved for marketingNCT05401214
• A Post-market Clinical Study to Collect Safety and Performance Data on Johnson & Johnson Surgical Vision ProductsCompletedNCT05394324
• A Study of Two Different Test Formulations Compared to the Reference Formulation of Macitentan in Healthy Adult ParticipantsCompletedNCT05392530Phase 1
• A Thorough QT Study of Aticaprant (JNJ-67953964) in Healthy Adult ParticipantsCompletedNCT05387759Phase 1
• A Study of Nipocalimab in Participants With Active Idiopathic Inflammatory MyopathiesActive, not recruitingNCT05379634Phase 2
• A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Compared to the Co-administration of the Separate Available Formulations of Darunavir and Cobicistat Under Fed Conditions in Healthy ParticipantsCompletedNCT05378906Phase 1
• Evidence for Health Improvement in People With Diabetes Using One Touch & Partner SolutionsStatus unknownNCT05354297Not applicable
• A Study of Guselkumab in Participants With Fistulizing, Perianal Crohn's DiseaseActive, not recruitingNCT05347095Phase 3
• A Study of Talquetamab and Teclistamab Each in Combination With a Programmed Cell Death Receptor-1 (PD-1) Inhibitor for the Treatment of Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT05338775Phase 1
• A Study of Implantation of CRENEOUS ENTERPRISE 2 Intracranial Stent in Participants With Severe Symptomatic Intracranial Atherosclerotic StenosisCompletedNCT05316311Not applicable
• Study of Erdafitinib Intravesical Delivery System for Localized Bladder CancerActive, not recruitingNCT05316155Phase 1/2
• A Study of High Risk Localized Prostate Cancer Participants Treated With Radical Prostatectomy and Perioperative Hormonal TherapyCompletedNCT05303558
• A Study of EPI-7386 in Combination With Abiraterone Acetate Plus Prednisone, or Apalutamide in Metastatic Castration-resistant Prostate Cancer (mCRPC)TerminatedNCT05295927Phase 1
• Use of the Impella BTR™ in Patients With Heart Failure: An Early Feasibility StudyActive, not recruitingNCT05291884Not applicable
• Clinical Trial to Evaluate Safety and Efficacy of a Facial and Lip Moisturizer in Adult Subjects Undergoing a Facial Dermatologic Procedure With Fractional CO2 LaserCompletedNCT05272787Not applicable
• Depuy Synthes Lower Extremity Shaft Nail RegistryCompletedNCT05272631
• A Study to Assess Feasibility of Using Clinician-directed and Digital Application Supported Cognitive Behavior Therapy (CBT) in Conjunction With Esketamine in Participants With Treatment-resistant DepressionWithdrawnNCT05268497Phase 1
• A Study of Ustekinumab in Pediatric Participants (U-POPS) With Juvenile Psoriatic Arthritis or PsoriasisCompletedNCT05252533Phase 1
• A Study of JNJ-77474462 (Bermekimab) in Healthy Chinese ParticipantsWithdrawnNCT05252520Phase 1
• A Study of Daratumumab-Based Therapies in Participants With Amyloid Light Chain (AL) AmyloidosisActive, not recruitingNCT05250973Phase 2
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative ColitisActive, not recruitingNCT05242484Phase 2
• A Study of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Crohn's DiseaseActive, not recruitingNCT05242471Phase 2
• A Study of Ustekinumab Treatment in Children With Crohn's DiseaseCompletedNCT05242458
• A Study of Cetrelimab in Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05242445Phase 1
• A Study of Adenovirus Serotype 26.Respiratory Syncytial Virus.Pre-Fusion F (Ad26.RSV.preF)-Based Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Mediated- Lower Respiratory Tract Disease (LRTD) in Japanese ParticipantsTerminatedNCT05242432Phase 3
• A Study of JNJ-42847922 (Seltorexant) in Healthy ParticipantsCompletedNCT05236868Phase 1
• A Study of Fixed Dose Combination of Macitentan/Tadalafil (10 mg/20 mg) Compared to the Reference Free Combination of Macitentan and Tadalafil in Healthy Adult ParticipantsCompletedNCT05236231Phase 1
• Confocal Laser Endomicroscopy Nodule Localization by Robotic BronchoscopyCompletedNCT05231278Not applicable
• A Study of an Eczema Spot Treatment in Providing Eczema Symptoms Relief and Lasting Itch Relief to Affected Skin AreaCompletedNCT05226143Not applicable
• A Trial Evaluating the Safety and Effectiveness of the Laminar Left Atrial Appendage Closure System in Subjects With Non-Valvular Atrial FibrillationCompletedNCT05224375Not applicable
• Post-trial Access for Nipocalimab in Participants With Warm Autoimmune Hemolytic Anemia (wAIHA)Temporarily not availableNCT05221619
• A Study of JNJ-64281802 in Healthy Adult ParticipantsCompletedNCT05201937Phase 1
• A Study to Assess the Acceptability of the Darunavir/Cobicistat (DRV/COBI) Fixed-dose Combination (FDC) Tablet in Human Immunodeficiency Virus (HIV)-1 Infected ChildrenCompletedNCT05197075Phase 1
• A Study of 14C JNJ-67953964 in Healthy Adult Male ParticipantsCompletedNCT05197062Phase 1
• A Study of Butamirate Citrate Syrup Versus (vs) Sinecod Syrup (Vanilla) in Adult Healthy Study VolunteersWithdrawnNCT05182047Phase 1
• A Study of Pentosan Polysulfate Sodium and the Development of Pigmentary Maculopathy and Pigmentary RetinopathyCompletedNCT05179460
• Pre-approval Access Single Patient Request for Teclistamab (JNJ-64007957)No longer availableNCT05161598
• A Study of JNJ-75105186 in Healthy Japanese and Chinese ParticipantsWithdrawnNCT05159128Phase 1
• A Study in Healthy Adult Participants to Assess the Effects of Ciclosporin Administration on RilematovirCompletedNCT05155007Phase 1
• A Study of JNJ-80202135 in Healthy Chinese Adult ParticipantsCompletedNCT05151692Phase 1
• A Study of Acute Respiratory Infections in Global Outpatient SettingCompletedNCT05148780Early Phase 1
• A Study of the ECHELON Contour Curved Cutter Stapler Device in Colorectal ProceduresTerminatedNCT05133141
• A Study of Olynth Saline/Ectomed Nasal Drops/Spray Based Upon Previous UsageCompletedNCT05126407
• A Study of 3 Investigational Products on the Microbiome and Scalp Attributes in Children With Curly HairCompletedNCT05123911Not applicable
• A Study of JNJ-73763989, JNJ-64300535, and Nucleos(t)Ide Analogs in Virologically Suppressed, Hepatitis B e Antigen (HBeAg)- Negative Participants With Chronic Hepatitis B Virus InfectionCompletedNCT05123599Phase 1
• A Study of Experimental MouthwashesCompletedNCT05121909Phase 4
• A Twelve Week Study of Experimental Mouth RinsesCompletedNCT05120141Phase 4
• Changes in Inflammatory Biomarkers When Symptomatic Contact Lens Wearers Are Refit in Acuvue Oasys 1-Day LensesCompletedNCT05120128Not applicable
• A Study to Evaluate the Effect of Hepatic Impairment on Lazertinib (JNJ-73841937)CompletedNCT05112952Phase 1
• A Study of a Rilpivirine Extended-Release Suspension in Healthy ParticipantsCompletedNCT05112939Phase 1
• A Standard of Care Study of Patients With Major Depressive Disorder Who Have Had an Inadequate Response to a Selective Serotonin Reuptake/Serotonin-Norepinephrine Reuptake Inhibitor AntidepressantTerminatedNCT05109195
• A Study to Determine the Abuse Potential of Seltorexant Compared to Suvorexant and ZolpidemCompletedNCT05106153Phase 1
• SURPASS Impella 5.5 StudyCompletedNCT05100836
• A Study of a Polymeric Surfactant Technology Cleanser in Sensitive Skin ParticipantsCompletedNCT05094700Not applicable
• A Long-term Extension Study of Ustekinumab in Pediatric ParticipantsActive, not recruitingNCT05092269Phase 3
• A Real-World Study for the TECNIS Synergy™ Intraocular LensCompletedNCT05090826Not applicable
• A Real-World Study in China for the TECNIS Eyhance™ Intraocular LensCompletedNCT05090813Not applicable
• Clinical Investigation of the TECNIS 1-Piece Intraocular LensWithdrawnNCT05090787Not applicable
• A Study of Ustekinumab or Guselkumab in Pediatric Participants With Active Juvenile Psoriatic ArthritisCompletedNCT05083182Phase 3
• A Study of Teclistamab in Combination With Daratumumab Subcutaneously (SC) (Tec-Dara) Versus Daratumumab SC, Pomalidomide, and Dexamethasone (DPd) or Daratumumab SC, Bortezomib, and Dexamethasone (DVd) in Participants With Relapsed or Refractory Multiple MyelomaActive, not recruitingNCT05083169Phase 3
• A Study of Guselkumab and Risankizumab in Healthy Participants and Participants With Psoriatic ArthritisTerminatedNCT05083078Phase 1
• A Study of Lazertinib (JNJ-73841937) in Healthy ParticipantsCompletedNCT05076877Phase 1
• A Clinical Trial to Evaluate the Safety and Efficacy of a Moisturizer Body Lotion in Adults of Atopic Dermatitis.CompletedNCT05062213Not applicable
• A Study of JNJ-77242113 in Healthy Japanese and Chinese ParticipantsCompletedNCT05062200Phase 1
• Evaluation of the TECNIS Symfony® Toric Intraocular LensCompletedNCT05053399Not applicable
• A Study of Talquetamab With Other Anticancer Therapies in Participants With Multiple MyelomaActive, not recruitingNCT05050097Phase 1
• A Study of Guselkumab and Interleukin-17 (IL-17) Inhibitor Therapies in Participants With Psoriatic Arthritis in Routine Clinical PracticeActive, not recruitingNCT05049798
• A Study to Assess Wound Healing Efficacies of Different Clean, Treat, and Protect Wound Care Regimens Compared to Standard of Care and UntreatedCompletedNCT05045183Not applicable
• ARX788 in Selected HER2-mutated or HER2-amplified/Overexpressed Solid Tumors (ACE-Pan Tumor-02)WithdrawnNCT05041972Phase 2
• A Study of JNJ-75220795 in Japanese ParticipantsTerminatedNCT05039710Phase 1
• Proof-of-concept Study for a New Intraocular Lens, MODEL C0001CompletedNCT05036070Not applicable
• A Study of Ustekinumab (STELARA) in Chinese Participants With Moderately to Severely Active Crohn's DiseaseCompletedNCT05029921Phase 4
• A Study of JNJ-75229414 for Metastatic Castration-resistant Prostate Cancer ParticipantsCompletedNCT05022849Phase 1

← Johnson & Johnson overview and focus areas